Manfredi E, van Zaane B, Gerdes V E A, Brandjes D P M, Squizzato A
Department of Clinical Medicine, University of Insubria, Varese, Italy.
Haemophilia. 2008 May;14(3):423-33. doi: 10.1111/j.1365-2516.2007.01642.x. Epub 2008 Jan 21.
Acquired von Willebrand's syndrome type I is the supposed main underlying cause of bleeding tendency in hypothyroid patients. The purpose of this systematic review was to summarize the published evidence on the association between hypothyroidism and acquired von Willebrand's syndrome. All published clinical epidemiological and interventional studies, case reports and in vitro studies that investigated the association between hypothyroidism and acquired von Willebrand's syndrome were identified by a computer-assisted search of the MEDLINE and EMBASE electronic databases. A quality assessment was performed for clinical epidemiological studies. A total of 41 papers were included. A total of 22 epidemiological in vivo studies, two in vitro studies and 47 case reports were finally analyzed. No high quality in vivo study was identified. Almost all bleeding episodes described in the case reports were mucocutaneous. von Willebrand factor (VWF) antigen value was available for 23 patients: median value 28 U/dL (range: 4-45); VWF activity was available for 24 patients: median value 28.5 U/dL (range: <3-55); factor VIII activity was available for 16 patients: median value 47 U/dL (range: 9-74). Acquired von Willebrand's syndrome may be the main factor responsible for bleeding diathesis in overt hypothyroid patients. Even if bleeding episodes are mainly mild and mucocutaneous, blood transfusion, drug administration or surgical procedure may be required.
获得性I型血管性血友病综合征被认为是甲状腺功能减退患者出血倾向的主要潜在原因。本系统评价的目的是总结已发表的关于甲状腺功能减退与获得性血管性血友病综合征之间关联的证据。通过计算机辅助检索MEDLINE和EMBASE电子数据库,识别了所有已发表的临床流行病学和干预性研究、病例报告以及体外研究,这些研究探讨了甲状腺功能减退与获得性血管性血友病综合征之间的关联。对临床流行病学研究进行了质量评估。共纳入41篇论文。最终分析了22项流行病学体内研究、2项体外研究和47例病例报告。未发现高质量的体内研究。病例报告中描述的几乎所有出血事件均为皮肤黏膜出血。23例患者可获得血管性血友病因子(VWF)抗原值:中位数为28 U/dL(范围:4 - 45);24例患者可获得VWF活性:中位数为28.5 U/dL(范围:<3 - 55);16例患者可获得因子VIII活性:中位数为47 U/dL(范围:9 - 74)。获得性血管性血友病综合征可能是显性甲状腺功能减退患者出血素质的主要原因。即使出血事件主要为轻度且是皮肤黏膜出血,也可能需要输血、给药或进行外科手术。